These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 338147)

  • 1. Phase II Study of beta-2'-deoxythioguanosine in adult acute leukemia.
    Omura GA; Vogler WR; Smalley RV; Maldonado N; Broun GO; Knospe WH; Ahn YS; Faguet GB
    Cancer Treat Rep; 1977 Oct; 61(7):1379-81. PubMed ID: 338147
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I evaluation of beta-2'-deoxythioguanosine in pediatric patients with leukemia.
    Higgins GR; Jamin DC; Shore NA; Momparler R; Hartman G; Siegel SE
    Cancer Treat Rep; 1985 Jun; 69(6):699-701. PubMed ID: 3860294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory adult acute leukemia with 5-azacytidine plus beta-2'-deoxythioguanosine.
    Omura GA; Vogler WR; Bartolucci A; Neely CL; Silberman H
    Cancer Treat Rep; 1979 Feb; 63(2):209-10. PubMed ID: 87270
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. A Southwest Oncology Group study.
    Gagliano RG; Panettiere FJ; Haas CD; Baker L; Hewlett J; Stuckey WJ; O'Bryan RM; Bottomley R; Heilburn LK
    Cancer Clin Trials; 1981; 4(4):401-5. PubMed ID: 7318121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with 5-azacytidine plus beta-2'-deoxythioguanosine in adult acute leukemia.
    Omura GA
    Cancer Treat Rep; 1977 Aug; 61(5):915-7. PubMed ID: 70273
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II trials of hexamethylmelamine, dianhydrogalactitol, razoxane, and beta-2'-deoxythioguanosine as single agents against advanced measurable tumors of the pancreas. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1985 Jun; 69(6):713-6. PubMed ID: 3926311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275).
    Douglass HO; Lavin PT; Evans JT; Mittelman A; Carbone PP
    Cancer Treat Rep; 1979 Aug; 63(8):1355-7. PubMed ID: 476709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of THP-adriamycin in acute leukemia].
    Tani Y; Hirayama F; Ogawa K; Mashimoto K; Kubota R; Kanekura J; Oguma S; Veta T; Nakamura H; Shibata M
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2573-4. PubMed ID: 6580842
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to highly purified L-asparaginase during therapy of acute leukemia.
    Hill JM; Loeb E; MacLellan A; Khan A; Roberts J; Shields WF; Hill NO
    Cancer Res; 1969 Aug; 29(8):1574-80. PubMed ID: 4896902
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of carminomycin on adult patients with acute leukemias].
    Faĭnshteĭn FE; Kovaleva LG; Vakhrusheva MV; Isaev VG; Abakumov EM
    Antibiotiki; 1977 Aug; 22(8):756-8. PubMed ID: 334058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology and toxicology of alpha-2'-deoxythioguanosine in cancer patients.
    LePage GA; Khaliq A
    Cancer Treat Rep; 1979 Jan; 63(1):53-7. PubMed ID: 421233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sulphatrimethoprim-nystatin combination in the prophylaxis of infection in acute leukaemia (author's transl)].
    Fernández-Rañada J; Vázquez L; Escudero A; Merino JL; Gómez-Reino F; Olmeda F; Lahuerta J; Larregla S
    Sangre (Barc); 1980; 25(4):461-5. PubMed ID: 6999646
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
    Masi M; Vivarelli F; Paolucci P; Vecchi V
    Minerva Pediatr; 1975 Sep; 27(28):1539-50. PubMed ID: 1101022
    [No Abstract]   [Full Text] [Related]  

  • 14. [A controlled randomized clinical trial of adult acute leukemia].
    Nagura E; Yamada K
    Rinsho Ketsueki; 1985 Jun; 26(6):821-30. PubMed ID: 3906171
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
    Winton EF; Hearn EB; Martelo O; Presant CA; Adler S; Vogler WR; Raney M; Logan T; Silberman HM; Omura GA
    Cancer Treat Rep; 1985; 69(7-8):807-11. PubMed ID: 2410119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinational chemotherapy of L1210 and L1210/ARA-C leukemia with 5-AZA-2'-deoxycytidine and beta-2'-deoxythioguanosine.
    Momparler RL; Momparler LF; Samson J
    Int J Cancer; 1982 Sep; 30(3):361-64. PubMed ID: 6182115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of AMSA in acute leukemia.
    Dupont JC; Garay GE; Scaghone C; Pavlovsky S; Woodley PV
    Cancer Treat Rep; 1982 Jul; 66(7):1596-7. PubMed ID: 7046933
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of amsacrine gluconate in refractory leukemia.
    Omura GA; Winton EF; Vogler WR; Zuckerman KS; Grillo-Lopez AJ
    Cancer Treat Rep; 1983 Dec; 67(12):1131-2. PubMed ID: 6580948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amsacrine in refractory adult acute leukemia: a pilot study of the Southeastern Cancer Study Group.
    Winton EF; Hearn EB; Vogler WR; Johnson L; Logan T; Raney M
    Cancer Treat Rep; 1983 Nov; 67(11):977-80. PubMed ID: 6580070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities for the clinical use of 5-azacytidine].
    Veselý J; Cihák A
    Vopr Onkol; 1977; 23(10):65-73. PubMed ID: 74127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.